Author
Listed:
- Stephen A. Newland
(University of Cambridge)
- Sarajo Mohanta
(Institute for Cardiovascular Prevention, Ludwig-Maximilians-University (LMU))
- Marc Clément
(University of Cambridge)
- Soraya Taleb
(Institut National de la Santé et de la Recherche Médicale)
- Jennifer A. Walker
(MRC Laboratory of Molecular Biology)
- Meritxell Nus
(University of Cambridge)
- Andrew P. Sage
(University of Cambridge)
- Changjun Yin
(Institute for Cardiovascular Prevention, Ludwig-Maximilians-University (LMU))
- Desheng Hu
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University)
- Lauren L. Kitt
(University of Cambridge)
- Alison J. Finigan
(University of Cambridge)
- Hans-Reimer Rodewald
(German Cancer Research Center)
- Christoph J. Binder
(Medical University of Vienna and Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences)
- Andrew N. J. McKenzie
(MRC Laboratory of Molecular Biology)
- Andreas J. Habenicht
(Institute for Cardiovascular Prevention, Ludwig-Maximilians-University (LMU))
- Ziad Mallat
(University of Cambridge
Institut National de la Santé et de la Recherche Médicale)
Abstract
Type-2 innate lymphoid cells (ILC2) are a prominent source of type II cytokines and are found constitutively at mucosal surfaces and in visceral adipose tissue. Despite their role in limiting obesity, how ILC2s respond to high fat feeding is poorly understood, and their direct influence on the development of atherosclerosis has not been explored. Here, we show that ILC2 are present in para-aortic adipose tissue and lymph nodes and display an inflammatory-like phenotype atypical of adipose resident ILC2. High fat feeding alters both the number of ILC2 and their type II cytokine production. Selective genetic ablation of ILC2 in Ldlr−/− mice accelerates the development of atherosclerosis, which is prevented by reconstitution with wild type but not Il5−/− or Il13−/− ILC2. We conclude that ILC2 represent a major innate cell source of IL-5 and IL-13 required for mounting atheroprotective immunity, which can be altered by high fat diet.
Suggested Citation
Stephen A. Newland & Sarajo Mohanta & Marc Clément & Soraya Taleb & Jennifer A. Walker & Meritxell Nus & Andrew P. Sage & Changjun Yin & Desheng Hu & Lauren L. Kitt & Alison J. Finigan & Hans-Reimer R, 2017.
"Type-2 innate lymphoid cells control the development of atherosclerosis in mice,"
Nature Communications, Nature, vol. 8(1), pages 1-11, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15781
DOI: 10.1038/ncomms15781
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15781. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.